Funding injection to advance vaccine development
A novel Q Fever vaccine is progressing to pre-clinical trials following a $1.87 million investment from the Department of Health into DMTC’s national Medical Countermeasures (MCM) Initiative. (more…)
Posted by Harry Baxter on August 5th, 2020 Tagged: collaboration, Countermeasures, defence technology, DMTC, DST, industry, innovation, technology